BioNexus Gene Lab Corp. (NASDAQ: BGLC) Stock Competitors & Peer Comparison
See BGLC's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Industrial - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for BGLC and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BGLC | $1.60 | +1.59% | 3.9M | -1.09 | -$1.49 | N/A |
| GWW | $1,309.27 | +0.18% | 61.4B | 30.03 | $43.31 | +0.73% |
| FAST | $51.22 | -0.44% | 58.1B | 42.93 | $1.18 | +1.89% |
| FERG | $241.28 | -0.79% | 46.4B | 20.47 | $11.70 | +1.46% |
| WCC | $346.23 | +0.69% | 16.5B | 24.03 | $14.08 | +0.56% |
| QXO | $13.80 | -2.23% | 13.8B | 88.83 | $0.15 | N/A |
| WSO-B | $309.28 | +0.00% | 13.5B | 26.19 | $11.81 | +4.03% |
| WSO | $313.30 | -1.98% | 12.9B | 26.09 | $12.05 | +4.03% |
| AIT | $340.50 | -1.64% | 12.6B | 32.14 | $10.59 | +0.59% |
| WCC-PA | $221.82 | +1.73% | 10.9B | 21.85 | $10.15 | +0.56% |
Stock Comparison
W.W. Grainger, Inc. (NYSE: GWW)
BGLC vs GWW Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, GWW has a market cap of 61.4B. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while GWW trades at $1,309.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas GWW's P/E ratio is 30.03. In terms of profitability, BGLC's ROE is -0.33%, compared to GWW's ROE of +0.49%. Regarding short-term risk, BGLC is more volatile compared to GWW. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check GWW's competition here
Fastenal Company (NASDAQ: FAST)
BGLC vs FAST Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, FAST has a market cap of 58.1B. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while FAST trades at $51.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas FAST's P/E ratio is 42.93. In terms of profitability, BGLC's ROE is -0.33%, compared to FAST's ROE of +0.34%. Regarding short-term risk, BGLC is more volatile compared to FAST. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check FAST's competition here
Ferguson plc (NYSE: FERG)
BGLC vs FERG Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, FERG has a market cap of 46.4B. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while FERG trades at $241.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas FERG's P/E ratio is 20.47. In terms of profitability, BGLC's ROE is -0.33%, compared to FERG's ROE of +0.34%. Regarding short-term risk, BGLC is more volatile compared to FERG. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check FERG's competition here
WESCO International, Inc. (NYSE: WCC)
BGLC vs WCC Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, WCC has a market cap of 16.5B. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while WCC trades at $346.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas WCC's P/E ratio is 24.03. In terms of profitability, BGLC's ROE is -0.33%, compared to WCC's ROE of +0.14%. Regarding short-term risk, BGLC is more volatile compared to WCC. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check WCC's competition here
QXO, Inc. (NYSE: QXO)
BGLC vs QXO Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, QXO has a market cap of 13.8B. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while QXO trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas QXO's P/E ratio is 88.83. In terms of profitability, BGLC's ROE is -0.33%, compared to QXO's ROE of -0.05%. Regarding short-term risk, BGLC is more volatile compared to QXO. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check QXO's competition here
Watsco, Inc. (NYSE: WSO-B)
BGLC vs WSO-B Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, WSO-B has a market cap of 13.5B. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while WSO-B trades at $309.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas WSO-B's P/E ratio is 26.19. In terms of profitability, BGLC's ROE is -0.33%, compared to WSO-B's ROE of +0.17%. Regarding short-term risk, BGLC is more volatile compared to WSO-B. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check WSO-B's competition here
Watsco, Inc. (NYSE: WSO)
BGLC vs WSO Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, WSO has a market cap of 12.9B. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while WSO trades at $313.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas WSO's P/E ratio is 26.09. In terms of profitability, BGLC's ROE is -0.33%, compared to WSO's ROE of +0.17%. Regarding short-term risk, BGLC is more volatile compared to WSO. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check WSO's competition here
Applied Industrial Technologies, Inc. (NYSE: AIT)
BGLC vs AIT Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, AIT has a market cap of 12.6B. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while AIT trades at $340.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas AIT's P/E ratio is 32.14. In terms of profitability, BGLC's ROE is -0.33%, compared to AIT's ROE of +0.22%. Regarding short-term risk, BGLC is more volatile compared to AIT. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check AIT's competition here
WESCO International, Inc. (NYSE: WCC-PA)
BGLC vs WCC-PA Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, WCC-PA has a market cap of 10.9B. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while WCC-PA trades at $221.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas WCC-PA's P/E ratio is 21.85. In terms of profitability, BGLC's ROE is -0.33%, compared to WCC-PA's ROE of +0.14%. Regarding short-term risk, BGLC is more volatile compared to WCC-PA. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check WCC-PA's competition here
Core & Main, Inc. (NYSE: CNM)
BGLC vs CNM Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, CNM has a market cap of 8.3B. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while CNM trades at $44.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas CNM's P/E ratio is 17.51. In terms of profitability, BGLC's ROE is -0.33%, compared to CNM's ROE of +0.23%. Regarding short-term risk, BGLC is more volatile compared to CNM. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check CNM's competition here
Pool Corporation (NASDAQ: POOL)
BGLC vs POOL Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, POOL has a market cap of 7.1B. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while POOL trades at $189.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas POOL's P/E ratio is 18.10. In terms of profitability, BGLC's ROE is -0.33%, compared to POOL's ROE of +0.32%. Regarding short-term risk, BGLC is more volatile compared to POOL. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check POOL's competition here
MSC Industrial Direct Co., Inc. (NYSE: MSM)
BGLC vs MSM Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, MSM has a market cap of 6.6B. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while MSM trades at $118.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas MSM's P/E ratio is 27.19. In terms of profitability, BGLC's ROE is -0.33%, compared to MSM's ROE of +0.17%. Regarding short-term risk, BGLC is more volatile compared to MSM. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check MSM's competition here
Xometry, Inc. (NASDAQ: XMTR)
BGLC vs XMTR Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, XMTR has a market cap of 4.5B. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while XMTR trades at $82.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas XMTR's P/E ratio is 151.13. In terms of profitability, BGLC's ROE is -0.33%, compared to XMTR's ROE of -0.09%. Regarding short-term risk, BGLC is more volatile compared to XMTR. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check XMTR's competition here
SiteOne Landscape Supply, Inc. (NYSE: SITE)
BGLC vs SITE Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, SITE has a market cap of 4.2B. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while SITE trades at $95.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas SITE's P/E ratio is 26.24. In terms of profitability, BGLC's ROE is -0.33%, compared to SITE's ROE of +0.10%. Regarding short-term risk, BGLC is more volatile compared to SITE. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check SITE's competition here
DXP Enterprises, Inc. (NASDAQ: DXPE)
BGLC vs DXPE Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, DXPE has a market cap of 2.9B. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while DXPE trades at $190.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas DXPE's P/E ratio is 32.62. In terms of profitability, BGLC's ROE is -0.33%, compared to DXPE's ROE of +0.18%. Regarding short-term risk, BGLC is more volatile compared to DXPE. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check DXPE's competition here
Dnow Inc. (NYSE: DNOW)
BGLC vs DNOW Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, DNOW has a market cap of 2.8B. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while DNOW trades at $15.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas DNOW's P/E ratio is 28.79. In terms of profitability, BGLC's ROE is -0.33%, compared to DNOW's ROE of -0.10%. Regarding short-term risk, BGLC is more volatile compared to DNOW. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check DNOW's competition here
Distribution Solutions Group, Inc. (NASDAQ: DSGR)
BGLC vs DSGR Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, DSGR has a market cap of 1.6B. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while DSGR trades at $34.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas DSGR's P/E ratio is 32.83. In terms of profitability, BGLC's ROE is -0.33%, compared to DSGR's ROE of +0.01%. Regarding short-term risk, BGLC is more volatile compared to DSGR. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check DSGR's competition here
ADI Global Distribution Inc. (NYSE: ADIG)
BGLC vs ADIG Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, ADIG has a market cap of 1.6B. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while ADIG trades at $22.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas ADIG's P/E ratio is N/A. In terms of profitability, BGLC's ROE is -0.33%, compared to ADIG's ROE of +0.00%. Regarding short-term risk, BGLC is more volatile compared to ADIG. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check ADIG's competition here
Global Industrial Co (NYSE: GIC)
BGLC vs GIC Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, GIC has a market cap of 1.5B. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while GIC trades at $39.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas GIC's P/E ratio is 17.51. In terms of profitability, BGLC's ROE is -0.33%, compared to GIC's ROE of +0.27%. Regarding short-term risk, BGLC is more volatile compared to GIC. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check GIC's competition here
Systemax Inc. (NYSE: SYX)
BGLC vs SYX Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, SYX has a market cap of 1.3B. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while SYX trades at $35.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas SYX's P/E ratio is N/A. In terms of profitability, BGLC's ROE is -0.33%, compared to SYX's ROE of +0.46%. Regarding short-term risk, BGLC is more volatile compared to SYX. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check SYX's competition here
Transcat, Inc. (NASDAQ: TRNS)
BGLC vs TRNS Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, TRNS has a market cap of 856.5M. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while TRNS trades at $91.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas TRNS's P/E ratio is 83.19. In terms of profitability, BGLC's ROE is -0.33%, compared to TRNS's ROE of +0.01%. Regarding short-term risk, BGLC is more volatile compared to TRNS. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check TRNS's competition here
Lawson Products, Inc. (NASDAQ: LAWS)
BGLC vs LAWS Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, LAWS has a market cap of 796.8M. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while LAWS trades at $40.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas LAWS's P/E ratio is N/A. In terms of profitability, BGLC's ROE is -0.33%, compared to LAWS's ROE of +0.01%. Regarding short-term risk, BGLC is more volatile compared to LAWS. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check LAWS's competition here
BlueLinx Holdings Inc. (NYSE: BXC)
BGLC vs BXC Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, BXC has a market cap of 645.2M. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while BXC trades at $85.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas BXC's P/E ratio is 61.87. In terms of profitability, BGLC's ROE is -0.33%, compared to BXC's ROE of -0.00%. Regarding short-term risk, BGLC is more volatile compared to BXC. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check BXC's competition here
Titan Machinery Inc. (NASDAQ: TITN)
BGLC vs TITN Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, TITN has a market cap of 421.5M. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while TITN trades at $18.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas TITN's P/E ratio is -8.26. In terms of profitability, BGLC's ROE is -0.33%, compared to TITN's ROE of -0.09%. Regarding short-term risk, BGLC is more volatile compared to TITN. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check TITN's competition here
WF International Limited Ordinary Shares (NASDAQ: WXM)
BGLC vs WXM Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, WXM has a market cap of 302.9M. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while WXM trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas WXM's P/E ratio is -0.92. In terms of profitability, BGLC's ROE is -0.33%, compared to WXM's ROE of -0.72%. Regarding short-term risk, BGLC is less volatile compared to WXM. This indicates lower risk in terms of short-term price fluctuations for BGLC.Check WXM's competition here
EVI Industries, Inc. (AMEX: EVI)
BGLC vs EVI Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, EVI has a market cap of 194.5M. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while EVI trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas EVI's P/E ratio is 33.58. In terms of profitability, BGLC's ROE is -0.33%, compared to EVI's ROE of +0.05%. Regarding short-term risk, BGLC is more volatile compared to EVI. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check EVI's competition here
Rectitude Holdings Ltd Ordinary Shares (NASDAQ: RECT)
BGLC vs RECT Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, RECT has a market cap of 17.7M. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while RECT trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas RECT's P/E ratio is 6.10. In terms of profitability, BGLC's ROE is -0.33%, compared to RECT's ROE of +0.13%. Regarding short-term risk, BGLC is more volatile compared to RECT. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check RECT's competition here
Ten-League International Holdings Limited Ordinary Shares (NASDAQ: TLIH)
BGLC vs TLIH Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, TLIH has a market cap of 17M. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while TLIH trades at $5.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas TLIH's P/E ratio is 3.74. In terms of profitability, BGLC's ROE is -0.33%, compared to TLIH's ROE of +0.49%. Regarding short-term risk, BGLC is less volatile compared to TLIH. This indicates lower risk in terms of short-term price fluctuations for BGLC.Check TLIH's competition here
Creative Global Technology Holdings Limited Ordinary Shares (NASDAQ: CGTL)
BGLC vs CGTL Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, CGTL has a market cap of 7.5M. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while CGTL trades at $4.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas CGTL's P/E ratio is 34.04. In terms of profitability, BGLC's ROE is -0.33%, compared to CGTL's ROE of -0.75%. Regarding short-term risk, BGLC is more volatile compared to CGTL. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check CGTL's competition here
JBDI Holdings Limited (NASDAQ: JBDI)
BGLC vs JBDI Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, JBDI has a market cap of 6.2M. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while JBDI trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas JBDI's P/E ratio is -26.10. In terms of profitability, BGLC's ROE is -0.33%, compared to JBDI's ROE of +0.07%. Regarding short-term risk, BGLC is less volatile compared to JBDI. This indicates lower risk in terms of short-term price fluctuations for BGLC.Check JBDI's competition here
urban-gro, Inc. (NASDAQ: UGRO)
BGLC vs UGRO Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, UGRO has a market cap of 2.3M. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while UGRO trades at $3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas UGRO's P/E ratio is -0.09. In terms of profitability, BGLC's ROE is -0.33%, compared to UGRO's ROE of +0.00%. Regarding short-term risk, BGLC is less volatile compared to UGRO. This indicates lower risk in terms of short-term price fluctuations for BGLC.Check UGRO's competition here
Houston Wire & Cable Company (NASDAQ: HWCC)
BGLC vs HWCC Comparison August 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 3.9M. In comparison, HWCC has a market cap of 0. Regarding current trading prices, BGLC is priced at $1.60 on the NASDAQ, while HWCC trades at $5.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -1.09, whereas HWCC's P/E ratio is N/A. In terms of profitability, BGLC's ROE is -0.33%, compared to HWCC's ROE of -0.13%. Regarding short-term risk, BGLC is more volatile compared to HWCC. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check HWCC's competition here